Knight Therapeutics buy krebskrebs
Start price
30.11.20
/
50%
€3.50
Target price
30.11.21
€4.00
Performance (%)
5.14%
End price
01.12.21
€3.68
Summary
This prediction ended on 01.12.21 with a price of €3.68. With a performance of 5.14%, the BUY prediction by krebskrebs for Knight Therapeutics closed with a slight gain. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Knight Therapeutics | 0.000% | 0.000% | 57.068% | 79.641% |
| iShares Core DAX® | 0,85 % | 0,39 % | 2,53 % | 52,00 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % | 25,15 % | 77,54 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % | 44,40 % | 64,68 % |
| iShares S&P 500 | 0,06 % | 0,78 % | 20,95 % | 63,01 % |
Comments by krebskrebs for this prediction
In the thread Knight Therapeutics diskutieren
In the thread Trading Knight Therapeutics
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten